Skip to main content
. 2021 Jan 24;18(3):1022. doi: 10.3390/ijerph18031022
CYC cyclophosphamide
CNO/CRMO chronic recurrent multifocal osteomyelitis
DP dynamic programming
EMA European Medicines Agency
FDA Food and Drug Administration
HKSJ Hartung-Knapp-Sidik-Jonkman method
mKH modified Knapp-Hartung method
MMF mycophenolate Mofetil
NNHM normal-normal hierarchical model
RAR response adaptive randomization